Nova Eye Medical Limited (ELXMF)
ELXMF Stock Price Chart
Explore Nova Eye Medical Limited interactive price chart. Choose custom timeframes to analyze ELXMF price movements and trends.
ELXMF Company Profile
Discover essential business fundamentals and corporate details for Nova Eye Medical Limited (ELXMF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
20 Jan 2010
Employees
—
Website
https://nova-eye.comCEO
Victor Previn
Description
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.
ELXMF Financial Timeline
Browse a chronological timeline of Nova Eye Medical Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Feb 2026
Earnings released on 27 Aug 2025
Revenue for the quarter reached $10.65M , missing expectations by -3.57%.
Earnings released on 21 Feb 2025
EPS came in at -$0.01 falling short of the estimated -$0.00 by -249.52%, while revenue for the quarter reached $7.87M , beating expectations by +0.11%.
Earnings released on 30 Oct 2024
Earnings released on 25 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $8.79M .
Earnings released on 23 Feb 2024
EPS came in at -$0.02 , while revenue for the quarter reached $6.90M , beating expectations by 0.00%.
Earnings released on 30 Jun 2023
EPS came in at -$0.03 , while revenue for the quarter reached $5.73M .
Earnings released on 31 Dec 2022
EPS came in at -$0.03 , while revenue for the quarter reached $5.73M , beating expectations by +1.38%.
Earnings released on 30 Jun 2022
EPS came in at -$0.02 , while revenue for the quarter reached $4.70M .
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $4.74M .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $5.07M .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $5.10M .
ELXMF Stock Performance
Access detailed ELXMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.